China's total settlement of COVID-19 vaccine expenses from its medical insurance fund nationwide was more than 150 billion yuan (US$21.55 billion) in 2021-22, the National Health care Security Administration said in a statement on Thursday.
The health insurance fund paid PCR testing expenses worth 4.3 billion yuan in 2022, the administration said.
